Lactobacillus reuteri
Selected indexed studies
- Lactobacillus reuteri ZJ617 attenuates metabolic syndrome via microbiota-derived spermidine. (Nat Commun, 2025) [PMID:39837844]
- Lactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms. (Front Cell Infect Microbiol, 2023) [PMID:37662007]
- Lactobacillus reuteri tryptophan metabolism promotes host susceptibility to CNS autoimmunity. (Microbiome, 2022) [PMID:36419205]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Lactobacillus reuteri ZJ617 attenuates metabolic syndrome via microbiota-derived spermidine. (2025) pubmed
- Lactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms. (2023) pubmed
- Lactobacillus reuteri tryptophan metabolism promotes host susceptibility to CNS autoimmunity. (2022) pubmed
- Lactobacillus reuteri for chronic periodontitis: focus on underlying mechanisms and future perspectives. (2024) pubmed
- β-Glucuronidase-Expressing Lactobacillus reuteri Triggers Irinotecan Enterotoxicity Through Depleting the Regenerative Epithelial Stem/Progenitor Pool. (2025) pubmed
- Polyphenols and Lactobacillus reuteri in oral health. (2022) pubmed
- Lactobacillus reuteri in Its Biofilm State Improves Protection from Experimental Necrotizing Enterocolitis. (2021) pubmed
- Lactobacillus reuteri inhibits Staphylococcus aureus-induced mastitis by regulating oxytocin releasing and gut microbiota in mice. (2024) pubmed
- Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study. (2013) pubmed
- Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin? (2021) pubmed